Innate Pharma SA Deferred Income
Innate Pharma SA (IPHYF) had Deferred Income of EUR 38.07 million as of 2021-06-30, per its 6-K filed 2021-09-15.
Discontinued › Notes
ifrs-full:DeferredIncome · last filed 2021-09-15
- 2021-06-30: Deferred Income 38.07M EUR.
- 2020-12-31: Deferred Income 43.97M EUR.
- 2020-06-30: Deferred Income 62.07M EUR.
- 2019-12-31: Deferred Income 89.11M EUR.
| Period end | Deferred Income |
|---|---|
| 2021-06-30 | 38.07M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 43.97M EUR 6-K · filed 2021-09-15 |
| 2020-06-30 | 62.07M EUR 6-K · filed 2021-09-15 |
| 2019-12-31 | 89.11M EUR 6-K · filed 2021-09-15 |
| 2018-12-31 | 150.19M EUR 20-F · filed 2021-04-27 |
| 2017-12-31 | 134.91M EUR 20-F · filed 2020-04-24 |